Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches

References 

1. Romagnoli S, Concannon PW. Clinical use of progestins in bitches and queens: a review. In:  Concannon PW,  England G,  Verstegen PJ,  Linde-Forsberg C editor. Recent advances in small animal reproduction. Ithaca, NY: IVIS; 2003;
2. Fraser HM, Sandow J, Seidel H, Rechenberg WJ. An implant of gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3–5 months. Acta Endocr Copenh. 1987;115:521–527
3. Vickery BH, McRae GI, Good Pasture JC, Sanders LM. Use of potent LHRH analogues for chronic contraception and pregnancy termination in dogs. J Reprod Fertil. 1989;(Suppl. 39):175–187
4. Trigg TE, Wright PJ, Armour AF, Williamson PE, Junaidi A, Martin GB, et al. Use of a GnRH analogue implant to produce reversible long term suppression of reproductive function in male and female domestic dogs. J Reprod Fertil. 2001;(Suppl. 57):255–261
5. Rubion S, Guerin C, Rivière-Godet E, Horspool L, Rutten AAJJL, Driancourt MA. Treatment with a subcutaneous GnRH agonist containing controlled release device suppresses FSH concentrations and ovarian function in bitches. In: Proceedings of Seventh ESDAR Meeting 2003. Dublin. 2003;
6. Edney ATB, Smith PM. Study of obesity in dogs visiting veterinary practices in the United Kingdom. Vet Rec. 1986;118:391–396
   • MEDLINE
7. Salmeri KR, Bloomberg MS, Scruggs SL, Shille V. Gonadectomy in immature dogs: effects on skeletal, physical and behavioural development. J Am Vet Med Assoc. 1991;198:1193–1203
   • MEDLINE